Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Advances in targeted therapy of cholangiocarcinoma
Annals of Medicine ( IF 4.4 ) Pub Date : 2024-02-15 , DOI: 10.1080/07853890.2024.2310196 Yuhang Li 1 , Jianfeng Yu 1, 2 , Yujing Zhang 2 , Chuang Peng 1, 3, 4 , Yinghui Song 2 , Sulai Liu 1, 2, 3, 4
Annals of Medicine ( IF 4.4 ) Pub Date : 2024-02-15 , DOI: 10.1080/07853890.2024.2310196 Yuhang Li 1 , Jianfeng Yu 1, 2 , Yujing Zhang 2 , Chuang Peng 1, 3, 4 , Yinghui Song 2 , Sulai Liu 1, 2, 3, 4
Affiliation
Cholangiocarcinoma (CCA) is a malignant tumor originating in the bile duct and its branching epithelium. Due to its high heterogeneity, there are no specific clinical indications at the early stage...
中文翻译：
胆管癌靶向治疗研究进展
胆管癌（CCA）是起源于胆管及其分支上皮的恶性肿瘤。由于其高度异质性，早期没有特定的临床适应症...
更新日期：2024-02-16
中文翻译：
胆管癌靶向治疗研究进展
胆管癌（CCA）是起源于胆管及其分支上皮的恶性肿瘤。由于其高度异质性，早期没有特定的临床适应症...
京公网安备 11010802027423号